Portefeuille d'ETF CANC (NASDAQ) - Page 3 | MetaTrader

Afficher le graphique complet

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

Chugai Pharmaceutical Co Ltd 1.2 M 23.7 K 0.7%

IOVA Iovance Biotherapeutics Inc 1.1 M 280.0 K 0.7%

INBX Inhibrx Biosciences Inc 1.1 M 10.2 K 0.6%

OLMA Olema Pharmaceuticals Inc 1.1 M 79.8 K 0.6%

CGEM Cullinan Therapeutics Inc 1.0 M 62.8 K 0.6%

NTRA Natera Inc 946.6 K 4 238.0 0.5%

First Tracks Biotherapeutics I 932.4 K 58.4 K 0.5%

IMCR Immunocore Holdings PLC 891.2 K 30.8 K 0.5%

BBOT BridgeBio Oncology Therapeutic 837.3 K 93.3 K 0.5%

CTMX CytomX Therapeutics Inc 824.4 K 229.0 K 0.5%

HCM HUTCHMED China Ltd 776.6 K 67.8 K 0.4%

ARVN Arvinas Inc 755.4 K 84.1 K 0.4%

JANX Janux Therapeutics Inc 751.7 K 51.5 K 0.4%

ANL Adlai Nortye Ltd 529.6 K 44.4 K 0.3%

TYRA Tyra Biosciences Inc 527.2 K 15.8 K 0.3%

ORIC ORIC Pharmaceuticals Inc 489.9 K 58.0 K 0.3%

SLS SELLAS Life Sciences Group Inc 378.9 K 40.7 K 0.2%

1
2
3

Nouvelles

Les actions de Cogent Biosciences grimpent après l'acceptation par la FDA de la demande d'approbation de médicament clé | Benzinga France